drdregen wrote:With all due respect Dr. Sclafani, the 'liberation procedure' doesn't work by itself. Can you honestly say it does? Or that the current trials will be successfully concluded so that vein dilation will become an approved mainstream therapy for MS given the current findings? (NL study as bellwether).
Regarding the video itself: I cannot see any inducements to get patients to purchase anything. It is informational only and focuses on the process, the science and the preliminary result in a single case study. If you wish to verify the science identified and revealed on the text screens, you might want to contact Dr. Saud Sidiq, Research Director and Senior Research Scientist, Multiple Sclerosis Research Center of New York, Dr. Robert Miller, Case Western University, or Dr. Warren Sherman, Director, Stem Cell Research and Regenerative Medicine, Center for Interventional Vascular Therapy, Skirball Center for Cardiovascular Diseases at Columbia U.
The video presentation was constructed by the researchers and followed the Case Western Study public video almost precisely, except with more explanation. Please focus on the novel therapy being demonstrated and attempt to review the video without bias. Notwithstanding the regenerative aspect of implanting autologous MSCs into the CNS, the innovation of implanting autologous stromal cells intravenously is good news for MS patients and may eventually prove useful as an additional and relatively simple intervention that will support the liberation therapy itself.
vesta wrote:Gold standard has been proposed to be catheter venography PLUS intravascular ultrasound, not catheter venography alone.
best of luck to you, vesta
Cece! I don't know what intravascular ultrasound means as a treatment and it doesn't appear as a subject. Please advise, thanks.
drdregen wrote:No, stents are not used. That’s the whole purpose behind the super-selective infusion of stem cells intraluminally; providing stability to the vein without need for a stent.
Users browsing this forum: Donnchadh